List of insiders holdings for REGENERON PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | 2024-06-13 16:01:19 | 2,177,667 178,259 | 2,355,926 | Form 4 |
2 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | 2024-06-12 16:10:49 | 868,994 241,951 | 1,110,945 | Form 4 |
3 | VAGELOS P ROY Director | 2023-04-05 16:02:23 | 312,578 154,526 | 467,104 | Form 4 |
4 | SANOFI-AVENTIS Sanofi-Aventis Amerique du Nord S.N.C. 10% Owner | 2020-06-17 17:10:15 | 279,766 0 | 279,766 | Form 13D |
5 | Sanofi 10% Owner | 2020-06-17 17:10:15 | 279,766 0 | 279,766 | Form 13D |
6 | GOLDBERG MURRAY A SVP Administration & Asst Secr | 2014-12-18 16:25:06 | 142,515 6,400 | 148,915 | Form 4 |
7 | RUPP RANDALL SVP, Manufuring Operations | 2007-04-17 14:25:18 | 142,137 0 | 142,137 | Form 4 |
8 | ROBERTS WILLIAM VP Reg Dev & Med Safety | 2014-02-06 16:41:18 | 16,644 55,634 | 72,278 | Form 5 |
9 | GULER HANS PETER VP Clinical Programs | 2004-10-12 12:02:08 | 67,152 0 | 67,152 | Form 4 |
10 | STAHL NEIL EVP Research and Development | 2024-12-18 16:02:59 | 48,829 10,454 | 59,283 | Form 4 |
11 | MURPHY ANDREW J EVP Research | 2024-12-18 16:02:34 | 49,074 4,326 | 53,400 | Form 4 |
12 | LAROSA JOSEPH J EVP General Counsel and Secret | 2024-12-18 16:01:51 | 30,075 9,371 | 39,446 | Form 4 |
13 | Van Plew Daniel P EVP & General Mgr, Industrial | 2024-12-18 16:03:11 | 34,792 1,100 | 35,892 | Form 4 |
14 | Landry Robert E EVP Finance CFO | 2024-02-06 16:08:17 | 35,480 270 | 35,750 | Form 4 |
15 | Powchik Peter SVP Clinical Development & Reg | 2016-12-19 16:15:06 | 30,714 4,133 | 34,847 | Form 4 |
16 | Terifay Robert J EVP Commercial | 2017-12-13 16:52:29 | 32,300 0 | 32,300 | Form 4 |
17 | SING GEORGE L Director | 2025-01-03 16:02:28 | 29,786 2,150 | 31,936 | Form 4 |
18 | Dworkin Peter VP Investor Relations & Commun | 2009-12-22 11:21:13 | 23,500 0 | 23,500 | Form 4 |
19 | SHOOTER ERIC M Director | 2014-02-13 19:38:09 | 15,000 5,085 | 20,085 | Form 4 |
20 | KOLINSKI STUART SVP General Counsel and Secret | 2010-06-07 16:14:10 | 16,329 3,710 | 20,039 | Form 4 |
21 | Aberman Michael S SVP Strategy Investor Relation | 2017-06-23 16:10:08 | 7,693 12,253 | 19,946 | Form 4 |
22 | Fenimore Christopher R. SVP Finance & CFO | 2024-12-18 16:01:20 | 16,265 3,462 | 19,727 | Form 4 |
23 | RYAN ARTHUR F Director | 2025-01-06 16:08:27 | 19,706 0 | 19,706 | Form 4 |
24 | INGRAM ROBERT ALEXANDER Director | 2015-05-27 16:02:35 | 14,833 0 | 14,833 | Form 4 |
25 | BROWN MICHAEL S Director | 2025-01-06 16:05:22 | 3,506 11,162 | 14,668 | Form 4 |
26 | McCourt Marion EVP Commercial | 2024-12-18 16:02:07 | 14,230 174 | 14,404 | Form 4 |
27 | McCorkle Douglas S VP Controller and Asst Treasur | 2015-12-29 19:44:10 | 6,866 4,129 | 10,995 | Form 4 |
28 | GILMAN ALFRED G Director | 2015-08-07 18:15:04 | 8,912 0 | 8,912 | Form 4 |
29 | GOLDSTEIN JOSEPH L Director | 2025-01-06 16:06:04 | 8,506 0 | 8,506 | Form 4 |
30 | BAKER CHARLES A Director | 2018-01-03 16:14:21 | 7,439 0 | 7,439 | Form 4 |
31 | Pitofsky Jason VP Controller | 2024-12-18 16:02:48 | 4,664 190 | 4,854 | Form 4 |
32 | Tessier-Lavigne Marc Director | 2023-01-05 16:16:35 | 4,363 0 | 4,363 | Form 4 |
33 | POON CHRISTINE A Director | 2025-01-06 16:07:40 | 4,310 0 | 4,310 | Form 4 |
34 | COLES N ANTHONY Director | 2025-01-06 16:12:14 | 3,517 0 | 3,517 | Form 4 |
35 | Bassler Bonnie L Director | 2025-01-06 16:04:09 | 3,506 0 | 3,506 | Form 4 |
36 | Zoghbi Huda Y Director | 2025-01-06 16:11:47 | 3,506 0 | 3,506 | Form 4 |
37 | Thompson Craig B. Director | 2025-01-06 16:13:03 | 2,578 0 | 2,578 | Form 4 |
38 | Schenkein David P Director | 2025-01-06 17:42:19 | 2,406 0 | 2,406 | Form 4 |
39 | Guarini Kathryn Director | 2025-01-06 16:06:55 | 2,406 0 | 2,406 | Form 4 |
40 | NOVARTIS PHARMA AG 10% Owner | 2005-11-10 14:56:08 | 0 0 | 0 | Form 13G |